AKT1 and colorectal carcinoma: Meanwhile, the immunofluorescence staining results of intracellular protein expression changes after ISL treatment were consistent with the Western blot results, as shown in Figure 4B. This suggests that ISL may inhibit the PI3K/AKT signalling pathway by up-regulating ESR2, thereby suppressing the growth of CRC cells.